hydroxyurea has been researched along with Obstructive Lung Diseases in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Six horses with COPD underwent a series of four antigen challenges, one month apart, with placebo pre-treatment on three occasions and fenleuton (4 days oral dosing 5 mg/kg) pre-treatment on one occasion." | 1.30 | Effect of the 5-lipoxygenase inhibitor, fenleuton, on antigen-induced neutrophil accumulation and lung function changes in horses with chronic obstructive pulmonary disease. ( Cunningham, FM; Lees, P; Marr, KA; Page, CP, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marr, KA | 1 |
| Lees, P | 1 |
| Page, CP | 1 |
| Cunningham, FM | 1 |
1 other study available for hydroxyurea and Obstructive Lung Diseases
| Article | Year |
|---|---|
Effect of the 5-lipoxygenase inhibitor, fenleuton, on antigen-induced neutrophil accumulation and lung function changes in horses with chronic obstructive pulmonary disease.
Topics: Animals; Antigens; Bronchodilator Agents; Female; Horse Diseases; Horses; Hydroxyurea; Leukocyte Cou | 1998 |